share_log

步长制药(603858.SH):水痘减毒活疫苗临床试验申请获受理

Shandong Buchang Pharmaceuticals (603858.SH): Application for clinical trials of the varicella attenuated live vaccine has been accepted.

Zhitong Finance ·  Dec 17, 2024 01:44

Shandong Buchang Pharmaceuticals (603858.SH) announced that its holding subsidiary Zhejiang Tianyuan Biological Pharmaceutical Co., Ltd.'s '...

According to the Zhitong Finance APP, Shandong Buchang Pharmaceuticals (603858.SH) announced that its holding subsidiary Zhejiang Tianyuan Biological Pharmaceutical Co., Ltd.'s application for clinical trial registration of the 'Varicella Live Attenuated Vaccine' has been accepted by the National Medical Products Administration, and a 'Notice of Acceptance' has been received. Indication for the varicella live attenuated vaccine: after vaccination with this vaccine, it can stimulate the body to produce immunity against the varicella-zoster virus. It is used for the prevention of varicella.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment